Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.
about
Female sexualityBremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trialFlibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility.New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin.Sexual function in women with polycystic ovary syndrome and their hormonal and clinical correlations.Depression, sexuality and fibromyalgia syndrome: clinical findings and correlation to hematological parameters.Evaluation and Management of Hypoactive Sexual Desire Disorder.
P2860
Q26795397-2EA8C35C-BBE9-4153-93E3-A78350DA8D21Q30276805-3D9A408E-80D8-4AFD-AB84-E0D470E776DDQ33166265-7C10E2A4-8E4E-4711-B367-1B246E471BDBQ38813758-7219D225-32F1-46B7-AF4F-D133D7C234A7Q39262633-559991BC-E5BE-44D9-8ADD-41C7252E1EB8Q47564761-450A245F-0449-4B47-A503-C8673EF9F1E4Q47930738-F2F4A596-D3DC-4385-B2CA-5544E021F164Q53437731-005B1D63-C1A6-4C8F-B981-B8DF055A9797
P2860
Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Benefits and risks of testoste ...... odiesterase type 5 inhibitors.
@ast
Benefits and risks of testoste ...... odiesterase type 5 inhibitors.
@en
type
label
Benefits and risks of testoste ...... odiesterase type 5 inhibitors.
@ast
Benefits and risks of testoste ...... odiesterase type 5 inhibitors.
@en
prefLabel
Benefits and risks of testoste ...... odiesterase type 5 inhibitors.
@ast
Benefits and risks of testoste ...... odiesterase type 5 inhibitors.
@en
P2860
P921
P356
P1433
P1476
Benefits and risks of testoste ...... odiesterase type 5 inhibitors.
@en
P2093
Carmita H N Abdo
Sandra Léa Bonfim Reis
P2860
P304
P356
10.6061/CLINICS/2014(04)11
P5008
P577
2014-01-01T00:00:00Z